Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Javier Torralba, Iranzo"'
Autor:
Alberto Martínez-Castelao, Aleix Cases, Alberto Torre Carballada, Javier Torralba Iranzo, Josep Bronsoms, Martí Vallès-Prats, Daniel Torán Monserrat, Elisabet Masso Jimenez
Publikováno v:
Nefrología (English Edition), Vol 35, Iss 2, Pp 179-188 (2015)
Background and objective: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13g/dL during the treatment with erythropoiesis stimulating agents (ESAs). This
Externí odkaz:
https://doaj.org/article/67b0e77f68554e5bb0963fd1594ebfa8
Autor:
Alberto, Martínez-Castelao, Aleix, Cases, Alberto Torre, Carballada, Javier Torralba, Iranzo, Josep, Bronsoms, Martí, Vallès-Prats, Daniel Torán, Monserrat, Elisabet Masso, Jimenez, José L, Górriz
Publikováno v:
Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia. 35(2)
The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13 g/dL during the treatment with erythropoiesis stimulating agents (ESAs). This study evaluated if there
Autor:
Alberto Torre Carballada, Josep Bronsoms, Elisabet Masso Jimenez, Daniel Torán Monserrat, Alberto Martínez-Castelao, Martí Vallès-Prats, Javier Torralba Iranzo, Aleix Cases
Publikováno v:
Nefrología (English Edition), Vol 35, Iss 2, Pp 179-188 (2015)
Nefrología, Vol 35, Iss 2, Pp 179-188 (2015)
Nefrología, Vol 35, Iss 2, Pp 179-188 (2015)
Background and objective: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13 g/dL during the treatment with erythropoiesis stimulating agents (ESAs). This